The ASCO Post: Improved Survival with Shorter Delays Between Diagnosis and Surgery and Before Initiating Adjuvant Chemotherapy

In a major study published in the prestigious journal JAMA Oncology, a large population based study has confirmed the previous observation that initiation of post-operative adjuvant chemotherapy becomes less effective if there are significant delays in the commencement of therapy after surgery. Dr. Mariana Chavez-MacGregor, MD, MSc, of University of Texas MD Anderson Cancer Center, Houston, and colleagues “observed that a delay in initiation of adjuvant chemotherapy of 91 or more days was associated with worse” overall survival in breast cancer-specific survival. According to the accompanying editorial by Adrienne G. Waks, MD, Tari King, MD, and Eric P. Winer, MD of Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, Boston, “thoughtfulness and attention to facilitate timely care is essential, and at this point it seems that added vigilance is warranted in the triple-negative breast cancer subset”.

The full article published in The ASCO Post can be found here.

Recent Posts